Form 4: Nurix Therapeutics Executive Sells Shares
Insider Transaction (Form 4)
Christine Ring, Chief Legal Officer of Nurix Therapeutics, Inc., sold 5,786 shares of common stock on October 2, 2026 for $23.19 per share.
Summary
- Option exercise/conversion: acquired 5,786 Common Stock at $8.72 ($50,454) on October 2, 2026; holds 14,896 after (Direct).
- Open-market sale: disposed of 5,786 Common Stock at $23.19 ($134,149) on October 2, 2026; holds 9,110 after (Direct).
- Option exercise/conversion: disposed of 5,786 Employee Stock Option (right to buy) on October 2, 2026; holds 111,251 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $134,149 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Christine Ring — Officer (Chief Legal Officer)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-10-02 | Option exercise/conversion | Common Stock | 5,786 | $9 | $50.5K | 14,896 |
| 2026-10-02 | Open-market sale | Common Stock | 5,786 | $23 | $134.1K | 9,110 |
| 2026-10-02 | Option exercise/conversion | Employee Stock Option (right to buy) | 5,786 | — | — | 111,251 |
Key Dates
| Date | Description |
|---|---|
| 2026-10-02 | Option exercise/conversion (5,786 shares) |
| 2026-10-02 | Open-market sale (5,786 shares) |
| 2026-10-02 | Option exercise/conversion (5,786 shares) |
Keywords
insider transaction, Form 4, NRIX, Nurix Therapeutics, Inc., bearish, Christine Ring
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.